Fulcrum Therapeutics, Inc. - Common Stock (FULC)

CUSIP: 359616109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
67,171,444
Total 13F shares
26,798,436
Share change
-114,572
Total reported value
$280,833,000
Price per share
$10.48
Number of holders
66
Value change
-$3,275,840
Number of buys
40
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 359616109?
CUSIP 359616109 identifies FULC - Fulcrum Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
TRV GP III, LLC
13F
Company
8.9%
5,962,202
$70,235,000 31 Mar 2021
13F
RTW INVESTMENTS, LP
13F
Company
4.8%
3,205,291
$37,758,000 31 Mar 2021
13F
FMR LLC
13F
Company
3.6%
2,415,731
$28,458,000 31 Mar 2021
13F
TRV GP IV, LLC
13F
Company
3.5%
2,343,154
$27,602,000 31 Mar 2021
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
1,525,885
$17,975,000 31 Mar 2021
13F
Casdin Capital, LLC
13F
Company
1.8%
1,241,176
$14,621,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
1.7%
1,128,579
$13,294,000 31 Mar 2021
13F
COWEN AND COMPANY, LLC
13F
Company
1.3%
881,832
$10,388,000 31 Mar 2021
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.3%
876,211
$10,322,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
1.3%
843,195
$9,933,000 31 Mar 2021
13F
Alphabet Inc.
13F
Company
1%
678,141
$7,988,000 31 Mar 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.93%
622,500
$7,333,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.89%
595,061
$7,010,000 31 Mar 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.86%
575,246
$6,776,000 31 Mar 2021
13F
Ikarian Capital, LLC
13F
Company
0.64%
426,739
$5,026,000 31 Mar 2021
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.61%
410,714
$4,838,000 31 Mar 2021
13F
Burrage Capital Management LLC
13F
Company
0.48%
319,819
$3,767,000 31 Mar 2021
13F
BESSEMER GROUP INC
13F
Company
0.43%
285,714
$3,366,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.42%
284,737
$3,354,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.4%
265,505
$3,127,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
0.38%
254,497
$2,998,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.29%
197,208
$2,323,000 31 Mar 2021
13F
Sio Capital Management, LLC
13F
Company
0.28%
191,272
$2,253,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.21%
143,202
$1,687,000 31 Mar 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.19%
126,068
$1,485,000 31 Mar 2021
13F
Parkman Healthcare Partners LLC
13F
Company
0.19%
125,738
$1,481,000 31 Mar 2021
13F
FIDUCIARY TRUST CO
13F
Company
0.19%
124,999
$1,472,000 31 Mar 2021
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.18%
121,302
$1,429,000 31 Mar 2021
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.12%
83,550
$984,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
0.1%
67,805
$799,000 31 Mar 2021
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.08%
50,884
$599,000 31 Mar 2021
13F
Darwin Global Management, Ltd.
13F
Company
0.07%
49,868
$587,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.07%
49,815
$587,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.06%
43,630
$514,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.06%
42,247
$497,000 31 Mar 2021
13F
COUNTRY TRUST BANK
13F
Company
0.06%
37,341
$440,000 31 Mar 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
31,594
$372,000 31 Mar 2021
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.04%
30,000
$353,000 31 Mar 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
25,687
$303,000 31 Mar 2021
13F
BRANDYWINE MANAGERS, LLC
13F
Company
0.03%
20,388
$240,000 31 Mar 2021
13F
PDT Partners, LLC
13F
Company
0.03%
20,343
$240,000 31 Mar 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
19,900
$234,000 31 Mar 2021
13F
Engineers Gate Manager LP
13F
Company
0.03%
17,144
$202,000 31 Mar 2021
13F
MYDA Advisors LLC
13F
Company
0.02%
15,737
$185,000 31 Mar 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.02%
15,700
$185,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
14,367
$169,000 31 Mar 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.02%
13,979
$165,000 31 Mar 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
12,355
$146,000 31 Mar 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
12,267
$145,000 31 Mar 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
11,460
$135,000 31 Mar 2021
13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock (FULC) as of Q2 2021

As of 30 Jun 2021, Fulcrum Therapeutics, Inc. - Common Stock (FULC) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,798,436 shares. The largest 10 holders included TRV GP III, LLC, RTW INVESTMENTS, LP, FMR LLC, TRV GP IV, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, COWEN AND COMPANY, LLC, BlackRock Inc., Casdin Capital, LLC, VANGUARD GROUP INC, and Alphabet Inc.. This page lists 66 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
68
Q2 2021 holders
66
Holder diff
-2
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.